Related Experiment Video

Updated: Jan 1, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

4.4K

[The examinations associating with hepatitis C virus and medical reimbursement]

K Kawata1, K Fukutake

  • 1Department of Laboratory Medicine, Tokyo Medical University, Shinjuku-ku, Tokyo 160-0023.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|September 28, 2001
PubMed

Insights

Hepatitis C virus (HCV) affects 1-2 million in Japan, potentially causing liver cirrhosis and cancer. Laboratory tests, including antibody and viral load detection, are crucial for diagnosis, treatment selection, and monitoring therapy response.

Area of Science:

  • Hepatology
  • Virology
  • Clinical Diagnostics

Context:

  • Hepatitis C virus (HCV) infection is a significant public health concern in Japan, with an estimated 1-2 million individuals affected.
  • HCV infection is a leading cause of liver cirrhosis and hepatocellular carcinoma, driving research interest.
  • Diagnostic approaches for HCV are categorized into host factor and virus factor detection methods.

Purpose:

  • To outline the classification and costs associated with various HCV diagnostic tests.
  • To describe the utility of host factor detection (antibody tests) for screening, auxiliary diagnosis of viremia, and treatment selection.
  • To explain the role of virus factor tests (e.g., viral load measurement) in guiding treatment decisions and assessing therapeutic response.

Summary:

  • HCV diagnostic methods include host factor detection (antibody tests) for screening and diagnosis, and virus factor tests (viral load) for treatment guidance and response assessment.
  • Antibody tests aid in initial infection screening, diagnosing viremia, and informing treatment choices.
  • Viral load measurements are essential for selecting appropriate therapies and evaluating treatment efficacy.

Impact:

  • Provides a comprehensive overview of laboratory testing strategies for HCV management.
  • Discusses the clinical applications of different HCV tests, aiding clinicians in patient management.
  • Addresses medical insurance coverage for HCV diagnostic procedures, potentially impacting healthcare accessibility.

More Related Videos

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

41.3K
A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.6K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
143
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
178
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
454
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
322